Erratum: Phase I study of bortezomib in refractory or relapsed acute leukemias (Clinical Cancer Research (May 15, 2004) 10 (3371-3377))

Jorge Cortes, Deborah Thomas, Charles Koller, Frances Giles, Elihu Estey, Stefan Faderl, Guillermo Garcia-Manero, David McConkey, Stacey L. Ruiz, Roberto Guerciolini, John Wright, Hagop Kantarjian

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalClinical Cancer Research
Volume10
Issue number22
StatePublished - Dec 15 2004
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Erratum : Phase I study of bortezomib in refractory or relapsed acute leukemias (Clinical Cancer Research (May 15, 2004) 10 (3371-3377)). / Cortes, Jorge; Thomas, Deborah; Koller, Charles; Giles, Frances; Estey, Elihu; Faderl, Stefan; Garcia-Manero, Guillermo; McConkey, David; Ruiz, Stacey L.; Guerciolini, Roberto; Wright, John; Kantarjian, Hagop.

In: Clinical Cancer Research, Vol. 10, No. 22, 15.12.2004.

Research output: Contribution to journalComment/debate

Cortes, J, Thomas, D, Koller, C, Giles, F, Estey, E, Faderl, S, Garcia-Manero, G, McConkey, D, Ruiz, SL, Guerciolini, R, Wright, J & Kantarjian, H 2004, 'Erratum: Phase I study of bortezomib in refractory or relapsed acute leukemias (Clinical Cancer Research (May 15, 2004) 10 (3371-3377))', Clinical Cancer Research, vol. 10, no. 22.
Cortes, Jorge ; Thomas, Deborah ; Koller, Charles ; Giles, Frances ; Estey, Elihu ; Faderl, Stefan ; Garcia-Manero, Guillermo ; McConkey, David ; Ruiz, Stacey L. ; Guerciolini, Roberto ; Wright, John ; Kantarjian, Hagop. / Erratum : Phase I study of bortezomib in refractory or relapsed acute leukemias (Clinical Cancer Research (May 15, 2004) 10 (3371-3377)). In: Clinical Cancer Research. 2004 ; Vol. 10, No. 22.
@article{0e877afe155d4d50af9a541a91e1db31,
title = "Erratum: Phase I study of bortezomib in refractory or relapsed acute leukemias (Clinical Cancer Research (May 15, 2004) 10 (3371-3377))",
author = "Jorge Cortes and Deborah Thomas and Charles Koller and Frances Giles and Elihu Estey and Stefan Faderl and Guillermo Garcia-Manero and David McConkey and Ruiz, {Stacey L.} and Roberto Guerciolini and John Wright and Hagop Kantarjian",
year = "2004",
month = "12",
day = "15",
language = "English (US)",
volume = "10",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - Erratum

T2 - Phase I study of bortezomib in refractory or relapsed acute leukemias (Clinical Cancer Research (May 15, 2004) 10 (3371-3377))

AU - Cortes, Jorge

AU - Thomas, Deborah

AU - Koller, Charles

AU - Giles, Frances

AU - Estey, Elihu

AU - Faderl, Stefan

AU - Garcia-Manero, Guillermo

AU - McConkey, David

AU - Ruiz, Stacey L.

AU - Guerciolini, Roberto

AU - Wright, John

AU - Kantarjian, Hagop

PY - 2004/12/15

Y1 - 2004/12/15

UR - http://www.scopus.com/inward/record.url?scp=9344247475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9344247475&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:9344247475

VL - 10

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 22

ER -